PAGEInsider
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| SEPN | Long Daniel D. | SVP, Drug Discovery | Aug 03 '26 | Option Exercise | 2.76 | 3,334 | 9,202 | 99,746 | Aug 05 |
| SEPN | Long Daniel D. | SVP, Drug Discovery | Aug 03 '26 | Sale | 34.47 | 3,334 | 114,920 | 96,412 | Aug 05 |
| SEPN | Long Daniel D. | SVP, Drug Discovery | Jul 01 '26 | Option Exercise | 2.76 | 3,333 | 9,199 | 99,745 | Jul 02 |
| SEPN | Long Daniel D. | SVP, Drug Discovery | Jul 01 '26 | Sale | 34.36 | 3,333 | 114,528 | 96,412 | Jul 02 |
| SEPN | Long Daniel D. | SVP, Drug Discovery | Jun 22 '26 | Option Exercise | 5.42 | 15,000 | 81,371 | 111,412 | Jun 24 |
| SEPN | Long Daniel D. | SVP, Drug Discovery | Jun 22 '26 | Sale | 35.51 | 15,000 | 532,582 | 96,412 | Jun 24 |
| SEPN | Long Daniel D. | SVP, Drug Discovery | Nov 10 '25 | Sale | 18.06 | 3,501 | 63,223 | 92,911 | Nov 13 |